NZ's AFT Pharma jumps on retaining earnings outlook for FY22

AFT Pharmaceuticals

06/01/2022 23:14

** Shares of AFT Pharmaceuticals Ltd  AFT.NZ  rise as much
as 3.4% to A$4.61 – their highest since Nov. 30 
    ** The drugmaker retains its outlook for an operating profit
of between NZ$18 million and NZ$23 million for the year ending
March 31, 2022  urn:newsml:reuters.com:*:nFWN2TM0R5
    ** Co says it is looking for a new licensee in Russia for
its pain relief medicine Maxigesic 
    ** Says, it is confident of its 2022 prospects, despite the
ongoing uncertainties of COVID-19 and the related global supply
chain disruptions 
    ** AFT set for its sharpest gain since Dec. 22 last year 

 (Reporting by Navya Mittal)
 ((Navya.Mittal@thomsonreuters.com;))